Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer. (February 2017)

Record Type:: Journal Article
Title:: Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer. (February 2017)
Main Title:: Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer
Authors:: Tolaney, S.
Savulsky, C.
Aktan, G.
Xing, D.
Almonte, A.
Karantza, V.
Diab, S.
Abstract:
Is Part Of:: European journal of cancer. Volume 72(2017)Supplement 1
Journal:: European journal of cancer
Issue:: Volume 72(2017)Supplement 1
Issue Display:: Volume 72, Issue 1 (2017)
Year:: 2017
Volume:: 72
Issue:: 1
Issue Sort Value:: 2017-0072-0001-0000
Page Start:: S16
Page End:
Publication Date:: 2017-02
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(17)30131-4 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 99.xml